Corporate Headquarters
Princess Margaret Hospital
Grand Bahamas Health Services
Sandilands Rehabilitation Centre
Online Tender Management System
Login
Search
Customer Support
Find a Physician
Drug Formulary
About
Hospitals & Services
Business Opportunities
News
Resources
Quality
Human Resources
Events
Staff Portal
Feedback
About PHA
Back to Results
New Search
Progesterone
Drug Class:
Hormonal Preparations
Dosage Form:
Implant
Strength:
Indications/Special comments:
Used in prevention of pregnancy over a long time (up to 5 years).
Dosage Administration:
Contraception (no hormonal contraceptive use in previous month):By subdermal implantation: Females of childbearing potential: 1 implant inserted during first 5 days of cycle, implant should be removed within 3 years of insertion. Contraception (postpartum): By subdermal implantation: Females of childbearing potential: 1 implant to be inserted 21 – 28 days after delivery, 1 implant to be inserted after 28 days postpartum in breast-feeding mothers; implant should be removed within 3 years of insertion. Contraception following abortion or miscarriage in the second trimester: By subdermal implantation: Females of childbearing potential: 1 implant to be inserted 21 – 28 days after abortion or miscarriage, implant should be removed within 3 years of insertion. Contraception following abortion or miscarriage in the first trimester: By subdermal implantation: Females of childbearing potential: 1 implant to be inserted within 5 days, implant should be removed within 3 years of insertion. Contraception (changing from other hormonal contraceptive): By subdermal implantation: Females of childbearing potential: Implant should be removed within 3 years of insertion (consult product literature).
[x close]
Drugs Search
List of Drugs
Important notices
Tender for Provision of Cleaning Services at GBHS (Grand Bahama)
Tender for the Provision of Security Guard Services at the Sandilands Rehab Centre
PHA Announces the Appointment of Dr Francis Williams as MCOS PMH